BNTX|Analyst Targets
BNTX|Company Info
BNTX|Insider Trading
BNTX|Fundamentals
BNTX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.86 | - | - |
| Q2'26 | $-2.13 | $-2.24 | -5.1% |
| Q1'26 | $-2.29 | $-1.95 | +15.0% |
| Q4'25 | $-2.02 | $-0.33 | +83.9% |
| Q4'24 | $0.37 | $1.08 | +188.9% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.1B | - | - |
| Q2'26 | $161M | $107M | -33.7% |
| Q1'26 | $249M | $118M | -52.5% |
| Q4'25 | $321M | $907M | +182.8% |
| Q4'24 | - | $1.2B | - |
BNTX|Monthly Returns
Market Data
BNTX Stock Snapshot
- Market cap
- 24.08B
- Day range
- $88.57 – $90.50
- News sentiment
- 35/100 · Bearish
- Analyst target
- $115.77 (+30.6%)
- Consensus
- Buy · 29 analysts
The signals on BNTX lean bearish, and the range position backs that up. Sector peers are worth watching - large caps in Healthcare tend to move together on rotation.
Behaviour On Record
What BNTX's own history says about today's numbers
- Realized volatility (21d)
- 44.1% 36th pct
- Below its peak
- -79.7%
- vs 200-day average
- -8.2%
- Up days (1y)
- 49%
BioNTech SE is currently running 44.1% annualised volatility over the last 21 sessions. Measured against BNTX's own 7 years of daily returns rather than a market-wide average, that is the 36th percentile — on the quiet side for this stock, against a typical reading of 52.4%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
BNTX is trading -79.7% below its running peak. Across 6 full years on file, its median worst-drawdown-in-a-year was -43.1%, and the deepest was -50.1% in 2021. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -8.2% from its 200-day moving average. Against every other day in its history, that gap ranks at the 39th percentile — close to the gap it normally carries. Over the past year BNTX closed higher on 49% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 8 years of records, BNTX finished the month higher 5 of 8 times, with a median return of +1.2% and an average of +3.0%. Its strongest month historically has been November at +19.1% on average, its weakest February at -4.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: BNTX has opened more than 2% away from the prior close in 243 of 1,758 sessions (13.8% of the time), with the largest gaps running +55.7% and -10.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, BNTX moved an average of 2.5% in the session after earnings, closing higher 3 of those 3 times, with a median move of +0.9% and a largest of +6.6%.
All figures computed from 1,760 daily closes between 2019-10-10 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against BNTX's own 7-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of BNTX's sector?
BioNTech SE sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, BNTX ranks 9th of 15 tracked industries, improving.
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #9 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on BNTX?
Canaccord Genuity most recently reiterated its rating on BioNTech SE to Buy on Oct 14, 2026 with a price target of $132 (from $136). Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.
- Latest action
- Canaccord Genuity — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 1
- Net rating momentum
- -1
Peers
BNTX peers
BiotechnologyMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| FMR LLC (Fidelity) | ▲ Buy | 7,571,805 | 2.82% | $704.56M | 2026-08-13 |
| BlackRock, Inc. | ▲ Buy | 1,854,966 | 0.69% | $172.60M | 2026-08-07 |
| Temasek Holdings (Private) Ltd | • Hold | 1,506,027 | 0.56% | $140.14M | 2026-08-07 |
| Baillie Gifford & Co | ▼ Sell | 592,380 | 0.22% | $55.12M | 2026-08-06 |
| Goldman Sachs Group Inc | ▲ Buy | 589,903 | 0.22% | $54.89M | 2026-08-14 |
| Morgan Stanley | ▲ Buy | 492,092 | 0.18% | $45.79M | 2026-08-13 |
| Bank of America Corp | ▼ Sell | 486,205 | 0.18% | $45.24M | 2026-08-14 |
| Balyasny Asset Management L.P. | ▲ Buy | 463,163 | 0.17% | $43.10M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 417,421 | 0.16% | $38.84M | 2026-08-14 |
| Marshall Wace, LLP | ▲ Buy | 382,147 | 0.14% | $35.61M | 2026-08-13 |
| Citadel Advisors LLC | ▼ Sell | 364,585 | 0.14% | $33.92M | 2026-09-02 |
| Citigroup Inc | ▲ Buy | 359,784 | 0.13% | $33.48M | 2026-08-03 |
| Point72 Asset Management, L.P. | ▼ Sell | 327,184 | 0.12% | $30.44M | 2026-08-14 |
| Two Sigma Investments, LP | ▲ Buy | 292,614 | 0.11% | $27.23M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 199,004 | 0.07% | $18.52M | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 142,852 | 0.05% | $13.29M | 2026-08-12 |
| Wellington Management Group LLP | ▼ Sell | 130,334 | 0.05% | $12.13M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 126,975 | 0.05% | $11.97M | 2026-08-12 |
| Susquehanna International Group, LLP | ▼ Sell | 126,616 | 0.05% | $11.78M | 2026-08-14 |
| Invesco Ltd. | ▲ Buy | 100,462 | 0.04% | $9.35M | 2026-08-14 |
| Palo Alto Investors LP | • Hold | 19,614 | 0.01% | $1.83M | 2026-08-19 |
| Wells Fargo & Company | ▲ Buy | 17,973 | 0.01% | $1.67M | 2026-08-14 |
| Verition Fund Management LLC | ▼ Sell | 4,658 | 0.00% | $433.4K | 2026-08-14 |
| Northern Trust Corp | ▼ Sold out | 0 | 0.00% | $0 | 2026-08-13 |
| Millennium Management LLC | ▼ Sold out | 0 | 0.00% | $0 | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Valerie Hoyle | House | OR04 | ▼ Sell | $1K - $15K | 2025-08-07 | 2025-09-12 |